Nvision Biomedical Technologies Launches Pedicle Screw System at NASS
LOS ANGELES – Nvision Biomedical Technologies, a San Antonio-based medical device and biologics manufacturer, debuted its focus® Pedicle Screw System today at the North American Spine Society (NASS) Annual Meeting, held at the Los Angeles Convention Center, September 26-29.
The Nvision focus Pedicle Screw System, which received clearance from the U.S. Food and Drug Administration (FDA) in April, keeps patient safety in mind by focusing on ease and flexibility of use by surgeons. The system offers both minimally invasive and open surgery options with standard double lead thread and midline cortical thread options.
The midline cortical thread has a fast-starting initial thread, which is ergonomically designed and allows the surgeon to move faster in surgery. Additionally, the cortical option provides surgeons the flexibility to utilize a midline approach and not just a pedicle approach. For minimally invasive procedures, surgeons have an option to use a tower attachment or an extended tulip design with break-away tabs. This innovative technology allows for common instruments across procedures giving surgeons a choice without having to worry about specific instrumentation per system. Additionally, focus provides benefits for the hospital and surgical support team as well by streamlining implant delivery; minimizing tray space and limiting the number of instruments.
“As we expand our product portfolio at Nvision, our goal is to create devices and instrumentation that address industry challenges and provide solutions for surgeons,” said Tom Zink, Nvision Senior Vice President of Product Development. The focus Pedicle Screw System was developed through collaboration with surgeons to make their concept of the optimum pedicle screw system a reality.
The focus Pedicle Screw System, which will be available to surgeons in December, is Nvision’s latest product to enter the market. The company, which was founded in 2013, has several products in the marketplace including four interbody fusion systems – the nv line, one anterior cervical plate system – the tangis® line, and a buttress plate system – the boundary® line. The interbody devices have multiple footprints to adapt to the general shape of the vertebral endplates. Each set is available in a variety of heights to accommodate patient variability. Additionally, Nvision offers products with Structural Encoding®, the industry’s most innovative solution for medical device identification with permanent direct part marking, as well as a portfolio of human tissue allograft products including celera birth tissue patches and fluids as well as forma musculoskeletal bone and sports medicine grafts.
About Nvision Biomedical Technologies
Nvision is a San Antonio-based medical device and biologics manufacturing company focused on providing surgeons implants that are paired with instrumentation and biologics to simplify and improve surgery procedures that help patients get back to their quality of life.
Nvision is committed to developing and manufacturing thoughtfully designed products combined with exceptional service that keep the patients, surgeons, healthcare providers and distribution partners in mind. Nvision aligns with surgeon thought leaders, key researchers, and development engineers from prestigious institutions to design, test, and bring to market the most innovative concepts.
For More Information